Is it time to complete the transition from Masaoka-Koga to TNM in thymic tumors?—the con perspective
Annemarie Shepherd · 2026
Read Is it time to complete the transition from Masaoka-Koga to TNM in thymic tumors?—the con perspective by Annemarie Shepherd (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13589325.txt.
Description
Radiation oncologist Annemarie Shepherd argues the case against fully replacing an older staging system for thymus gland tumors, in this 2026 article. These tumors are rare. For forty years, doctors have staged them with the Masaoka-Koga system, which grew out of surgical experience and predicts outcomes well. A newer system, built on the standard cancer staging manual, sorts tumors by anatomy instead.
The newer approach was drawn from records of more than 8,000 patients and matches stage to survival and return rates. Shepherd's side of the debate stresses what the older system still does well, including its long track record in guiding surgery and follow-up treatment. The piece is one half of a pro-and-con exchange. Readers weighing how these cancers should be classified will find the strongest reasons here for keeping the established tool in use.
Catalog record
| CREATOR | Annemarie Shepherd |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |